B-Cell Lymphoma | Advanced Cancer | Skin Cancer and Darker Skin, 11/20/2024

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Stories of Cancer Research: Treatment for Resistant Aggressive B-Cell Lymphoma
headshot of Justin Storm   Read Justin's story in the NCI Fiscal Year 2026 Annual Plan and Professional Judgment Budget Proposal. After four standard treatments for non-Hodgkin lymphoma failed to work, Justin enrolled in an NCI clinical trial testing a five-drug treatment called ViPOR.

Read More
Coping with Advanced Cancer Long Term
a couple with a young girl stands for a family photo   Long-term cancer survivors may need cancer treatment for the rest of their lives—or go on and off treatment for many years—to keep their cancer at bay. Learn what steps you can take to help your physical, mental, and financial health during this time.

Read More
How Do Black People with Cancer View Clinical Research?
a middle-aged Balck woman talks with a health care provider   Black people with cancer are much less likely to join clinical trials than White people. Results from a new study may help explain why and help research staff talk with and recruit more Black participants.

Read More
Skin Cancer in People with Darker Skin
a Black man in a sun hat and sun glasses looks up   Anyone can get skin cancer, including people with black or brown skin. Learn about the causes of skin cancer on darker skin, how to find it early, and see photos of skin cancer on darker skin tones.

Read More
Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma

In a trial with nearly 1,000 people, treatment with nivolumab (Opdivo) and chemotherapy was better at getting rid of cancer and keeping it under control than the current standard treatment. The nivolumab combination also had fewer side effects.

Read More

No Benefit for Extended Lymph Node Surgery for Bladder Cancer

A clinical trial compared two types of surgery for people with localized muscle-invasive bladder cancer. The trial found that removing a larger group of lymph nodes did not improve survival compared with standard lymph node surgery.

Read More

Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor (AT/RT)

Central nervous system AT/RT is a rare, fast-growing cancer that begins in the brain and spinal cord. It usually occurs in children aged 3 years and younger, but it can occur at any age. Learn more about AT/RT on this updated page, including its symptoms, diagnosis, and treatment.

Read More

 
Contact Us
Cancer Information Specialist talks on a headset   Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.